-
Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
24 Oct 2025 14:10 GMT
… lung cancer into non-small cell lung cancer (NSCLC) and small cell lung cancer … lung cancer.
Current treatment modalities for lung cancer include … Abraxane® and Pazenirl® are used in the clinical treatment of lung cancer … CPT-NPs inhibited lung tumor growth by …
-
<![CDATA[First-Line Sacituzumab Govitecan After Endocrine Therapy Fails to Improve PFS in HR+/HER2-Negative Breast Cancer ]]>
07 Nov 2025 17:32 GMT
… capecitabine, paclitaxel, or nab-paclitaxel (Abraxane). Treatment continued until disease progression … additional phase 3 studies in lung cancer and gynecologic malignancies.
“[Sacituzumab govitecan …
-
Meitheal Pharmaceuticals releases generic Abraxane
03 Jun 2025 22:59 GMT
… is a generic form of Abraxane.
The 100mg/vial single … or metastatic non-small cell lung cancer.
[Read more: Meitheal intros 2 …
-
<![CDATA[China’s Center for Drug Evaluation Grants Breakthrough Therapy Designation to Ivonescimab in TNBC]]>
04 Nov 2025 18:51 GMT
… or metastatic non–small cell lung cancer (NSCLC) resistant to EGFR TKI … ;m2 of IV nab-paclitaxel (Abraxane) on days 1, 8, and …
-
Cipla receives USFDA approval for Generic Abraxane
11 Apr 2025 05:07 GMT
… of Bristol Myers Squibb’s Abraxane® in the United States.
Cipla … is a therapeutic equivalent to Abraxane®, a widely used chemotherapy drug … or metastatic non-small cell lung cancer (NSCLC), and metastatic adenocarcinoma of …
-
Chinese generic drug for breast, pancreatic, and lung cancer approved in EU market
31 Jul 2024 22:56 GMT
… ;s and Celgene's Abraxane®(Nab-paclitaxel). Apexelsin® is developed … cancer and non-small cell lung cancer (NSCLC), as well as a …
-
Human medicines European public assessment report (EPAR): Abraxane, paclitaxel, Date of authorisation: 11/01/2008, Revision: 31, Status: Authorised
30 Jan 2025 17:24 GMT
… worse and survival. In contrast, Abraxane was more effective than conventional … metastatic adenocarcinoma of the pancreas, Abraxane was shown to improve overall … non-small cell lung cancer, 33% of patients receiving Abraxane and carboplatin responded …
-
Hanmi Pharma continues to unveil new anticancer drug pipelines globally
29 Oct 2025 08:24 GMT
… safety profile in colorectal and lung cancer animal models using STING mRNA … animal models when combined with Abraxane. Furthermore, the p53 mRNA-targeting …
-
Clinical Trials for Oral, Inhaled and Intravenous Drug Delivery System for Lung Cancer and Emerging Nanomedicine-Based Approaches
21 Dec 2023 04:45 GMT
… lung cancers. The two broad histological subtypes of lung cancer are small cell lung cancer … specifically accumulate in lung tumor tissues, improving drug … targeted delivery to lung tumors is a promising … .
One example is Abraxane (nab-paclitaxel). When …
-
Unveiling the Hidden Risks: An Update Decade-Long Analysis of Abraxane-Related Adverse Events from the FAERS Database
14 Nov 2024 09:57 GMT
… cell lung cancer, and pancreatic carcinoma.6–8
Abraxane was … the analysis specifically targeted Abraxane-related effects.
Results … understand their association with Abraxane. Overall, these … -squamous non-small-cell lung cancer (IMpower130): a multicentre, …
About
© 1995-2025